🔗 Share this article

This year's prestigious award in medical science has been granted for revolutionary discoveries that illuminate how the immune system targets harmful pathogens while protecting the body's own cells.

Three renowned researchers—Japan's Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

Their work uncovered unique "sentinels" within the defense system that remove malfunctioning immune cells capable of harming the body.

These findings are now enabling new therapies for autoimmune diseases and cancer.

These laureates will divide a monetary award worth 11 million Swedish kronor.

Crucial Findings

"Their research has been essential for comprehending how the immune system functions and the reason we don't all develop severe autoimmune diseases," commented the head of the Nobel Committee.

This trio's studies explain a fundamental mystery: In what way does the defense system protect us from countless infections while leaving our own tissues unharmed?

Our body's protection system uses immune cells that scan for indicators of disease, including viruses and germs it has not met before.

Such cells employ detectors—known as receptors—that are produced by chance in a vast number of combinations.

This gives the immune system the ability to combat a broad range of invaders, but the randomness of the mechanism inevitably produces immune cells that may target the host.

Protectors of the Immune System

Researchers previously understood that a portion of these harmful white blood cells were eliminated in the immune organ—the site where immune cells mature.

This year's award honors the identification of T-reg cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any immune cells that assault the healthy cells.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The Nobel panel stated, "The discoveries have established a novel area of investigation and spurred the development of new treatments, for example for cancer and autoimmune diseases."

In malignancies, regulatory T-cells block the system from fighting the tumor, so studies are focused on lowering their quantity.

For autoimmune diseases, trials are exploring increasing T-reg cells so the body is not being harmed. A similar approach could also be effective in reducing the risks of transplanted organ rejection.

Pioneering Experiments

Professor Sakaguchi, of a Japanese institution, conducted experiments on mice that had their thymus removed, leading to self-attack conditions.

He showed that injecting immune cells from other mice could prevent the disease—suggesting there was a system for preventing immune cells from attacking the body.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in rodents and people that resulted in the identification of a genetic factor vital for the way T-regs operate.

"The groundbreaking work has revealed how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," commented a leading physiology expert.

"The work is a remarkable example of how fundamental biological study can have far-reaching implications for human health."